BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2203524)

  • 1. Morphological and molecular characterization of spontaneous myogenic differentiation in a human rhabdomyosarcoma cell line.
    Shapiro DN; Houghton PJ; Hazelton BJ; Germain GS; Murti KG; Rahman A; Houghton JA
    Cancer Res; 1990 Sep; 50(18):6002-9. PubMed ID: 2203524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
    Liu LN; Dias P; Houghton PJ
    Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
    Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J
    Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation induction in the human rhabdomyosarcoma cell line TE-671. A morphological, biochemical and molecular analysis.
    Ramp U; Gerharz CD; Engers R; Marx N; Gabbert HE
    Anticancer Res; 1995; 15(1):181-8. PubMed ID: 7733631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of myogenic differentiation program in cultured normal postmitotic mononucleated myoblasts and the aberrant differentiation in rhabdomyosarcoma cells].
    Lin ZX; Zhang ZQ; Han YL; Zhou LX; Mei HL; Holtzer H
    Shi Yan Sheng Wu Xue Bao; 1994 Mar; 27(1):79-89. PubMed ID: 8042410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aphidicolin induces myogenic differentiation in the human rhabdomyosarcoma cell line KFR.
    Cinatl J; Cinatl J; Driever PH; Rabenau H; Novak M; Stefanik M; Kornhuber B; Doerr HW
    Cell Biol Int; 1994 Apr; 18(4):271-8. PubMed ID: 8044142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Density-dependent arrest of DNA replication is accompanied by decreased levels of c-myc mRNA in myogenic but not in differentiation-defective myoblasts.
    Sejersen T; Sümegi J; Ringertz NR
    J Cell Physiol; 1985 Dec; 125(3):465-70. PubMed ID: 4066768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of memory, differentiation, and repression of c-myc and p53 genes in human RD/TE-671 cells induced by a ureido-derivative of pyridine (UDP-4).
    Pappas IS; Sophianos D; Tzartos S; Tsiftsoglou AS
    Cell Growth Differ; 1996 Jun; 7(6):797-809. PubMed ID: 8780893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation.
    La Rocca SA; Crouch DH; Gillespie DA
    Oncogene; 1994 Dec; 9(12):3499-508. PubMed ID: 7970710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p18INK4c and p27KIP1 are required for cell cycle arrest of differentiated myotubes.
    Myers TK; Andreuzza SE; Franklin DS
    Exp Cell Res; 2004 Nov; 300(2):365-78. PubMed ID: 15475001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of proteasome in myogenic differentiation of murine myocytes and human rhabdomyosarcoma cells.
    Mugita N; Honda Y; Nakamura H; Fujiwara T; Tanaka K; Omura S; Shimbara N; Ogawa M; Saya H; Nakao M
    Int J Mol Med; 1999 Feb; 3(2):127-37. PubMed ID: 9917519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD.
    Knudsen ES; Pazzagli C; Born TL; Bertolaet BL; Knudsen KE; Arden KC; Henry RR; Feramisco JR
    Cancer Res; 1998 May; 58(9):2042-9. PubMed ID: 9581851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.
    Ma H; Urquidi V; Wong J; Kleeman J; Goodison S
    Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
    Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
    Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
    Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
    J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs.
    Lollini PL; De Giovanni C; Del Re B; Landuzzi L; Nicoletti G; Prodi G; Scotlandi K; Nanni P
    Cancer Res; 1989 Jul; 49(13):3631-6. PubMed ID: 2471586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP effects on myogenic gene expression in rhabdomyosarcoma cells.
    Wasserman LM; Newsham I; Huang HJ; Cavenee WK
    Exp Cell Res; 1996 Aug; 227(1):55-62. PubMed ID: 8806451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.